ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 163 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2018. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $404,284 | +248.3% | 182,110 | +149.5% | 0.00% | – |
| Q1 2023 | $116,070 | -65.9% | 73,000 | +33.7% | 0.00% | – |
| Q4 2022 | $340,158 | +18.1% | 54,600 | +27.1% | 0.00% | – |
| Q3 2022 | $288,000 | +23.1% | 42,953 | +16.7% | 0.00% | – |
| Q2 2022 | $234,000 | +78.6% | 36,800 | +30.0% | 0.00% | – |
| Q1 2022 | $131,000 | -7.7% | 28,300 | 0.0% | 0.00% | – |
| Q4 2021 | $142,000 | -58.7% | 28,300 | -0.9% | 0.00% | – |
| Q3 2021 | $344,000 | -43.0% | 28,570 | 0.0% | 0.00% | – |
| Q2 2021 | $604,000 | -9.4% | 28,570 | +20.2% | 0.00% | – |
| Q1 2021 | $667,000 | -14.7% | 23,770 | -21.0% | 0.00% | – |
| Q4 2020 | $782,000 | -30.1% | 30,070 | 0.0% | 0.00% | -100.0% |
| Q3 2020 | $1,118,000 | -39.9% | 30,070 | -17.1% | 0.00% | 0.0% |
| Q2 2020 | $1,861,000 | +78.9% | 36,270 | +10.0% | 0.00% | 0.0% |
| Q1 2020 | $1,040,000 | -47.1% | 32,970 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $1,966,000 | -14.1% | 32,970 | -47.2% | 0.00% | 0.0% |
| Q3 2019 | $2,290,000 | -21.2% | 62,464 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $2,906,000 | +162.5% | 62,464 | +126.6% | 0.00% | +100.0% |
| Q1 2019 | $1,107,000 | -12.7% | 27,570 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $1,268,000 | -18.0% | 27,570 | -20.9% | 0.00% | 0.0% |
| Q3 2018 | $1,547,000 | +13.2% | 34,870 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,367,000 | -37.6% | 34,870 | +15.2% | 0.00% | -50.0% |
| Q1 2018 | $2,189,000 | -4.9% | 30,270 | -13.4% | 0.00% | 0.0% |
| Q4 2017 | $2,302,000 | +84.0% | 34,970 | +40.0% | 0.00% | +100.0% |
| Q3 2017 | $1,251,000 | -10.1% | 24,970 | -17.0% | 0.00% | 0.0% |
| Q2 2017 | $1,392,000 | +38.0% | 30,070 | +5.3% | 0.00% | 0.0% |
| Q1 2017 | $1,009,000 | +157.4% | 28,570 | -8.6% | 0.00% | – |
| Q4 2016 | $392,000 | -9.5% | 31,270 | 0.0% | 0.00% | – |
| Q3 2016 | $433,000 | +40.1% | 31,270 | 0.0% | 0.00% | – |
| Q2 2016 | $309,000 | -18.3% | 31,270 | +39.8% | 0.00% | – |
| Q1 2016 | $378,000 | -24.1% | 22,370 | 0.0% | 0.00% | – |
| Q4 2015 | $498,000 | -11.2% | 22,370 | -5.9% | 0.00% | – |
| Q3 2015 | $561,000 | -87.5% | 23,770 | -56.5% | 0.00% | -100.0% |
| Q2 2015 | $4,471,000 | +223.3% | 54,690 | +266.1% | 0.00% | +300.0% |
| Q1 2015 | $1,383,000 | -26.0% | 14,940 | -67.7% | 0.00% | -50.0% |
| Q4 2014 | $1,870,000 | +33.9% | 46,230 | -19.1% | 0.00% | +100.0% |
| Q3 2014 | $1,397,000 | +53.5% | 57,130 | -0.5% | 0.00% | 0.0% |
| Q2 2014 | $910,000 | +5.7% | 57,430 | +0.9% | 0.00% | 0.0% |
| Q1 2014 | $861,000 | +10.1% | 56,928 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $782,000 | +39000.0% | 56,928 | +57989.8% | 0.00% | – |
| Q3 2013 | $2,000 | – | 98 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,402,973 | $6,120,132 | 5.31% |
| Two Seas Capital LP | 2,941,872 | $4,089,202 | 0.89% |
| Parkman Healthcare Partners LLC | 2,132,309 | $2,963,910 | 0.51% |
| TANG CAPITAL MANAGEMENT LLC | 1,850,000 | $2,571,500 | 0.38% |
| Ikarian Capital, LLC | 1,705,605 | $2,370,791 | 0.38% |
| Monaco Asset Management SAM | 695,302 | $966,470 | 0.27% |
| ARMISTICE CAPITAL, LLC | 9,193,000 | $12,778,270 | 0.18% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 3,469,634 | $4,822,791 | 0.17% |
| WASATCH ADVISORS LP | 13,139,556 | $18,263,983 | 0.11% |
| XTX Topco Ltd | 416,752 | $579,285 | 0.10% |